Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Approaches to a Patient With Anemia Who Is Refusing a Blood Transfusion.

American family physician·2024
Same author

The Challenges of Discharge Against Medical Advice: Conflict and Consequences.

American family physician·2023
Same author

Sepsis: Diagnosis and Management.

American family physician·2020
Same author

Large Cell Acanthoma of the Conjunctiva: Clinicopathologic and Immunohistochemical Features.

Ocular oncology and pathology·2019
Same author

Heat-Related Illnesses.

American family physician·2019
Same author

Hypertrophic Cardiomyopathy: an Often Silent and Delayed Diagnosis.

American family physician·2018

Related Experiment Video

Updated: May 24, 2026

Comprehensive Evaluation of the Effectiveness and Safety of Placenta-Targeted Drug Delivery Using Three Complementary Methods
09:04

Comprehensive Evaluation of the Effectiveness and Safety of Placenta-Targeted Drug Delivery Using Three Complementary Methods

Published on: September 10, 2018

When a fetus survives methotrexate exposure.

Tammy Donoway1, John Mandeville, Robert Gauer

  • 1Womack Army Medical Center, Fort Bragg, NC 28310, USA. tammy.donoway@us.army.mil

The Journal of Family Practice
|March 7, 2012
PubMed
Summary

Medical counseling is crucial for patients undergoing medical abortion or when pregnancy is unexpected. Healthcare providers offer vital support and information in these sensitive situations.

Area of Science:

  • Reproductive Health
  • Pharmacology

Background:

  • Medical abortion protocols require careful patient management.
  • Unintended pregnancies necessitate timely and accurate information.

Observation:

  • Patient counseling is a critical component of care, regardless of the indication for medication use.
  • The role of healthcare providers extends beyond prescribing to encompass comprehensive patient support.

Findings:

  • Counseling addresses potential treatment failures in medical abortion.
  • Guidance is essential when medications are used in unsuspected pregnancies.

Implications:

  • Effective communication ensures patient safety and informed decision-making.
  • Enhanced patient support improves outcomes in reproductive healthcare scenarios.

More Related Videos

Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells
05:45

Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells

Published on: October 10, 2025

Related Experiment Videos

Last Updated: May 24, 2026

Comprehensive Evaluation of the Effectiveness and Safety of Placenta-Targeted Drug Delivery Using Three Complementary Methods
09:04

Comprehensive Evaluation of the Effectiveness and Safety of Placenta-Targeted Drug Delivery Using Three Complementary Methods

Published on: September 10, 2018

Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells
05:45

Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells

Published on: October 10, 2025